Table IV.

Comparison of selected parameters between patients with stable CAD and ACS

Parameter	Stable CAD	ACS	P-value
N (%)	273 (67%)	137 (33%)	–
Age [years]*	65.5 ±10.5	65.3 ±11.2	0.84
Sex (F/M)	102 (25%)/171 (42%)	42 (10%)/95 (23%)	0.18
25(OH)D [ng/ml]**	15.6 (4.0–48.4)	13.6 (4.5–42.9)	< 0.01
Patients in groups according to the level of 25(OH)D:
0 – < 10	51 (12%)	35 (9%)	0.30
≥ 10 – < 20	148 (36%)	74 (18%)
≥ 20 – < 30	58 (14%)	22 (5%)
≥ 30	16 (4%)	6 (2%)
Smoking (No/Yes/Ex-smokers)	153 (37%)/61 (15%)/59 (14%)	75 (18%)/47 (12%)/15 (4%)	< 0.01
Patients in groups according to CASSS:
0	96 (23%)	16 (4%)	< 0.001
1	65 (16%)	56 (14%)
2	74 (18%)	41 (10%)
3	38 (9%)	24 (6%)
Hyperlipidaemia (No/Yes)	123 (31%)/142 (36%)	67 (17%)/65 (16%)	0.42

^*Data presented as mean ± SD;

^**data presented as median and range; other data presented as number of subjects (% of whole group).